Addison Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44.4K | Hold |
535
| – | – | 0.01% | 423 |
|
|
2025
Q1 | $43.4K | Hold |
535
| – | – | 0.01% | 402 |
|
|
2024
Q4 | $48.2K | Buy |
535
+115
| +27% | +$10.4K | 0.01% | 394 |
|
|
2024
Q3 | $41.5K | Hold |
420
| – | – | 0.01% | 417 |
|
|
2024
Q2 | $38.9K | Sell |
420
-150
| -26% | -$13.9K | 0.01% | 408 |
|
|
2024
Q1 | $54.1K | Hold |
570
| – | – | 0.02% | 352 |
|
|
2023
Q4 | $50.9K | Sell |
570
-23
| -4% | -$2.05K | 0.02% | 355 |
|
|
2023
Q3 | $43.3K | Hold |
593
| – | – | 0.02% | 346 |
|
|
2023
Q2 | $49.3K | Sell |
593
-200
| -25% | -$16.6K | 0.02% | 317 |
|
|
2023
Q1 | $60.4K | Sell |
793
-125
| -14% | -$9.53K | 0.03% | 280 |
|
|
2022
Q4 | $76.2K | Sell |
918
-189
| -17% | -$15.7K | 0.05% | 247 |
|
|
2022
Q3 | $88K | Buy |
1,107
+60
| +6% | +$4.77K | 0.05% | 203 |
|
|
2022
Q2 | $78K | Sell |
1,047
-295
| -22% | -$22K | 0.05% | 217 |
|
|
2022
Q1 | $121K | Buy |
1,342
+200
| +18% | +$18K | 0.07% | 195 |
|
|
2021
Q4 | $128K | Buy |
1,142
+722
| +172% | +$80.9K | 0.08% | 161 |
|
|
2021
Q3 | $53K | Hold |
420
| – | – | 0.04% | 178 |
|
|
2021
Q2 | $57K | Buy |
+420
| New | +$57K | 0.05% | 173 |
|
|
2020
Q4 | $39K | Buy |
+280
| New | +$39K | 0.04% | 198 |
|